Acute Gout

12 clinical trials · Condition

Record	Firm	Date
A Phase Ib/II Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout (NCT05588908)	Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.	2022-06-29
Clinical Study of Genakumab for Injection in Patients With Acute Gout (NCT05328531)	Changchun GeneScience Pharmaceutical Co., Ltd.	2021-05-22
Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ Fusion Protein in the Treatment of Acute Gout (NCT05925166)	Lihua Duan	2020-09-01
Efficacy and Safety of HuZhen Capsule for Treatment of Patients With Acute Gout (NCT02674776)	Quan Jiang	2015-09-01
Apremilast Therapy for Acute Gouty Arthritis (NCT00997581)	Dartmouth-Hitchcock Medical Center	2010-04-01
Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study. (NCT01080131)	Novartis Pharmaceuticals	2010-03-01
Targeted Dose Finding of Canakinumab (ACZ885) for Management of Acute Flare in Refractory or Contraindicated Gout Patients (NCT00798369)	Novartis	2008-11-01
A Study Evaluating the Effect of Etoricoxib and Indomethacin in the Treatment of Acute Gout (0663-081)(COMPLETED) (NCT00142558)	Organon and Co	2005-01-01

Every clearance here is in the API, with alerts when new ones post.